Serum HMGB1 and IDO expression levels were significantly correlated with lymph node metastasis and clinical stage (P<0.001), but there was no significant correlation with age, sex and depth of tumor invasion (P>0.05) (Tables 2, 3). Here, IDO1 is linked to metastatic malignant neoplasm in the lymph nodes.